DRIO: Future Brightens with $40M Raise & Sanofi Deal
By John Vandermosten, CFA
NASDAQ:DRIO
READ THE FULL DRIO RESEARCH REPORT
EXCLUSIVE: DarioHealth CEO, Erez Raphael To Appear On Benzinga’s Live YouTube TV At 1:30 p.m. ET On Tuesday
Click To Tune In Here... https://www.youtube.com/watch?v=DECZDla3Qds
DRIO: 2022 Outlook, Physimax Acquisition
By John Vandermosten, CFA
NASDAQ:DRIO
READ THE FULL DRIO RESEARCH REPORT
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning trading, 152 companies set new 52-week lows.
DarioHealth Enters Agreement To Acquire Physimax; Co. To Issue 256,660 Shares Of Common Stock Plus $500K Cash Payment
Dario's third all-equity acquisition in the last 12 months brings cutting edge vision technology to the company's comprehensive digital therapeutics platform
NEW YORK, Jan. 20, 2022 /PRNewswire/ -- DarioHealth
DarioHealth Announces 2 New Contracts Within Employer, Provider Market; Terms Not Disclosed
DarioHealth Corp. (NASDAQ:DRIO), a leader in the global digital therapeutics (DTx) market, announced new contracts today to provide its highly personalized digital therapeutics beginning in the first quarter of
DRIO: 47 New Contracts Year to Date
By John Vandermosten, CFA
NASDAQ:DRIO
READ THE FULL DRIO RESEARCH REPORT
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at multiple conferences.
DRIO: A Torrent of New Contracts
By John Vandermosten, CFA
NASDAQ:DRIO
READ THE FULL DRIO RESEARCH REPORT
DarioHealth Reports Partnership With Leading National Benefits Administrative Platform To Provide Full Suite Of Integrated Digital Therapeutic, Health Solutions Starting Jan. 2022, No Terms Disclosed
New partnership makes Dario's full suite of digital therapeutics available to National Group Benefits Platform's large population of employers
NEW YORK, Nov. 3, 2021 /PRNewswire/ -- DarioHealth Corp.